Self-reported factors influencing adherence to oral psoriasis treatment
Dermatology Online Journal · 06.07.2026 · 32 (3)
DOI: 10.25251/i71hs71j ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Dermatology Online Journal, online erschienen am 06.07.2026. Verfasst von Brett R Shaffer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA. Hauptthemen laut MEDLINE: Psoriasis, Drug Monitoring, Medication Adherence, Protein Kinase Inhibitors. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Psoriasis impairs quality of life, and treatment efficacy is limited by poor adherence. Although patients prefer oral therapies, adherence to oral medications can also be low.
Objective
To examine factors influencing adherence to deucravacitinib, an oral selective tyrosine kinase 2 inhibitor.
Methods
Forty adults with plaque psoriasis were provided deucravacitinib 6 mg daily and an electronic monitoring dock that recorded dose events. Participants were randomized to standard monitoring or monitoring with electronic reminders. After study completion, participants were stratified into the most (top 20%, T20) and least (bottom 20%, B20) adherent groups. Short-answer qualitative interviews were conducted at study conclusion, and responses were grouped into themes based on content analysis.
Results
Twenty-eight participants completed the study. Mean adherence was 98.6% ± 0.9% in T20 (n = 13) and 82.5% ± 10.7% in B20 (n = 6). All participants self-reported taking the medication as prescribed. The T20 participants reported understanding how deucravacitinib works and cited electronic reminders as helpful for adherence. The B20 most frequently relied on routine to help with adherence.
Conclusion
Greater understanding of therapy and use of reminders were associated with higher adherence. Patients relying on routine may benefit from structured reminder systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Center for Dermatology Research, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Sensal Health, Chapel Hill, NC, USA.
- Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Department of Social Sciences & Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Zitieren
APA
Shaffer, B. R., Lovell, K. K., Greenzaid, J. D., Zaino, M., Subramanian, V., Sirdeshmukh, D., Wiegandt, N., Richardson, I., & Feldman, S. R. (2026). Self-reported factors influencing adherence to oral psoriasis treatment. Dermatology Online Journal, 32(3). https://doi.org/10.25251/i71hs71j
Vancouver
Shaffer BR, Lovell KK, Greenzaid JD, Zaino M, Subramanian V, Sirdeshmukh D, et al. Self-reported factors influencing adherence to oral psoriasis treatment. Dermatology Online Journal. 2026;32(3). doi:10.25251/i71hs71j
BibTeX
@article{Shaffer2026,
author = {Shaffer, Brett R and Lovell, Katie K and Greenzaid, Jonathan D and Zaino, Mallory and Subramanian, Vani and Sirdeshmukh, Deepak and Wiegandt, Nestor and Richardson, Irma and Feldman, Steven R},
title = {Self-reported factors influencing adherence to oral psoriasis treatment},
journal = {Dermatology Online Journal},
year = {2026},
volume = {32},
number = {3},
doi = {10.25251/i71hs71j}
}
EUVIMED